Linear regression between SF-36 PCS and UCLA SCTC GITI score adjusted for age, disease duration, sex, and ethnicity (n = 113).
ß | Standard Error | 95% CI for ß | p | |
---|---|---|---|---|
Dependent variable = SF-36 MCS | ||||
UCLA SCTC GITI score | −6.94 | 2.27 | −11.44; −2.44 | 0.0029 |
Age | −0.04 | 0.09 | −0.21; −0.14 | 0.7006 |
Disease duration | 0.08 | 0.10 | −0.12; 0.28 | 0.4397 |
White ethnicity | 2.34 | 2.97 | −3.54; 8.23 | 0.4317 |
Women vs men R2 adj = 0.04621 | 2.04 | 3.43 | −4.75; 8.82 | 0.5536 |
Dependent variable = SF-36 PCS | ||||
UCLA SCTC GITI score | −7.31 | 2.43 | −12.12; −2.49 | < 0.001 |
Age | −0.13 | 0.10 | −0.32; 0.06 | 0.0033 |
Disease duration | −0.09 | 0.11 | −0.31; 0.13 | 0.1922 |
White ethnicity | 2.36 | 3.18 | −3.93; 8.65 | 0.4599 |
Women vs men R2 adj = 0.04621 | 1.96 | 3.67 | −5.29; 9.22 | 0.5932 |
SF-36: Medical Outcomes Study Short-Form 36 questionnaire; MCS: mental component summary; PCS: physical component summary; UCLA SCTC GITI: University of California at Los Angeles Scleroderma Clinical Trial Consortium GI Tract Instrument.